Adam

Eurofound launches the third round of its online survey Living, working and COVID-19

Eurofound’s Living, working and COVID-19 online survey aims to capture the far-reaching implications of the pandemic for the way people live and work across Europe. Two rounds of the online survey have been carried out to date: one in April 2020, when most Member States were in lockdown, and one in July, when society and […]

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 February 2021

Review of amfepramone medicines started EMA has started a review of obesity medicines that contain amfepramone. These medicines are authorised in some EU countries as treatment for patients with obesity (body mass index of at least 30 kg/m2) in whom other weight-reduction methods have not worked on their own. Amfepramone medicines are authorised to be used […]